Pure Bioscience Inc (PURE) – Strategy, SWOT and Corporate Finance Report

Pure Bioscience Inc (PURE) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Pure Bioscience Inc (Pure Bioscience) develops and commercializes proprietary antimicrobial products. The company’s products find application in the areas of food processing, food service, healthcare, personal care, and food safety. Its initial products contain a non-toxic antimicrobial agent, broad-spectrum, silver dihydrogen citrate. Pure Bioscience provides disinfecting, cleaning and sanitizing product lines to foodservice, food processing and food manufacturing customers. The company markets products under Axenohl, Axen, Silverion, and PURE brand names. It also manufactures and sells SDC-based formulations to manufacturers for use as a raw material ingredient. Pure Bioscience is headquartered in Rancho Cucamonga, California, the US.

Scope

• Detailed information on Pure Bioscience Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Pure Bioscience Inc in the form of a SWOT analysis

• An in-depth view of the business model of Pure Bioscience Inc including a breakdown and examination of key business segments

• News about Pure Bioscience Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Pure Bioscience Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Pure Bioscience Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Pure Bioscience Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Cantel Medical LLC

NovaSterilis Inc

Advantec MFS Inc

The Clorox Co

PRIMUS Sterilizer Company LLC

Steris Corp

CareFusion Corp

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Pure Bioscience Inc - Key Facts

Pure Bioscience Inc - Key Employees

Pure Bioscience Inc - Key Employee Biographies

Pure Bioscience Inc - Major Products and Services

Pure Bioscience Inc - History

Pure Bioscience Inc - Company Statement

Pure Bioscience Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Pure Bioscience Inc - Business Description

R&D Overview

Pure Bioscience Inc - Corporate Strategy

Pure Bioscience Inc - SWOT Analysis

SWOT Analysis - Overview

Pure Bioscience Inc - Strengths

Pure Bioscience Inc - Weaknesses

Pure Bioscience Inc - Opportunities

Pure Bioscience Inc - Threats

Pure Bioscience Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Pure Bioscience Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jun 14, 2023: PURE Bioscience Reports Fiscal 2023 Third Quarter And Nine-Month Financial Results

Mar 17, 2023: PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results

Dec 14, 2022: PURE Bioscience Reports Fiscal First Quarter 2023 Financial Results

Oct 28, 2022: PURE Bioscience Reports Fiscal 2022 Financial Results

Jun 14, 2022: PURE Bioscience Reports Fiscal 2022 Third Quarter and Nine-Month Financial Results

Mar 15, 2022: PURE Bioscience Reports Fiscal 2022 Second Quarter And Six-Month Financial Results

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Pure Bioscience Inc, Key Facts

Pure Bioscience Inc, Key Employees

Pure Bioscience Inc, Key Employee Biographies

Pure Bioscience Inc, Major Products and Services

Pure Bioscience Inc, History

Pure Bioscience Inc, Subsidiaries

Pure Bioscience Inc, Key Competitors

Pure Bioscience Inc, Ratios based on current share price

Pure Bioscience Inc, Annual Ratios

Pure Bioscience Inc, Annual Ratios (Cont…1)

Pure Bioscience Inc, Annual Ratios (Cont…2)

Pure Bioscience Inc, Interim Ratios

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Pure Bioscience Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Pure Bioscience Inc, Performance Chart (2019 – 2023)

Pure Bioscience Inc, Ratio Charts

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports